Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
LivaNova PLC stock logo
LIVN
LivaNova
$45.95
+2.5%
$39.56
$32.48
$57.35
$2.51B0.84649,297 shs932,281 shs
Envista Holdings Co. stock logo
NVST
Envista
$18.77
+0.5%
$16.78
$14.22
$23.00
$3.18B0.992.57 million shs1.27 million shs
SI-BONE, Inc. stock logo
SIBN
SI-BONE
$18.90
-0.8%
$16.10
$11.70
$20.05
$805.42M0.82382,655 shs485,058 shs
Warby Parker Inc. stock logo
WRBY
Warby Parker
$21.61
+1.9%
$17.27
$12.46
$28.68
$2.26B2.11.93 million shs1.63 million shs
20 Stocks to Sell Now Cover

Today, we are inviting you to take a free peek at our proprietary, exclusive, and up-to-the-minute list of 20 stocks that Wall Street's top analysts hate.

Many of these appear to have good fundamentals and might seem like okay investments, but something is wrong. Analysts smell something seriously rotten about these companies. These are true "Strong Sell" stocks.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
LivaNova PLC stock logo
LIVN
LivaNova
+2.45%+6.39%+5.60%+17.31%-23.45%
Envista Holdings Co. stock logo
NVST
Envista
+0.45%+2.62%+11.46%+1.65%+1.24%
SI-BONE, Inc. stock logo
SIBN
SI-BONE
-0.84%+0.21%+8.19%+17.68%+34.62%
Warby Parker Inc. stock logo
WRBY
Warby Parker
+1.97%+1.92%+33.76%+2.40%+25.08%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
LivaNova PLC stock logo
LIVN
LivaNova
2.8009 of 5 stars
3.53.00.00.02.01.71.3
Envista Holdings Co. stock logo
NVST
Envista
4.0082 of 5 stars
2.24.00.03.84.10.01.9
SI-BONE, Inc. stock logo
SIBN
SI-BONE
3.7797 of 5 stars
2.53.00.03.33.42.50.6
Warby Parker Inc. stock logo
WRBY
Warby Parker
1.8115 of 5 stars
2.32.00.00.02.73.30.6
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
LivaNova PLC stock logo
LIVN
LivaNova
3.00
Buy$59.2929.02% Upside
Envista Holdings Co. stock logo
NVST
Envista
2.33
Hold$20.237.78% Upside
SI-BONE, Inc. stock logo
SIBN
SI-BONE
3.00
Buy$22.5019.05% Upside
Warby Parker Inc. stock logo
WRBY
Warby Parker
2.61
Moderate Buy$22.885.87% Upside

Current Analyst Ratings Breakdown

Latest SIBN, NVST, LIVN, and WRBY Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
5/29/2025
Warby Parker Inc. stock logo
WRBY
Warby Parker
Piper Sandler
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOverweight ➝ Overweight$20.00 ➝ $25.00
5/27/2025
Envista Holdings Co. stock logo
NVST
Envista
Baird R W
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeHold ➝ Strong-Buy
5/27/2025
Envista Holdings Co. stock logo
NVST
Envista
Robert W. Baird
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeNeutral ➝ Outperform$21.00 ➝ $23.00
5/22/2025
Warby Parker Inc. stock logo
WRBY
Warby Parker
Roth Capital
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingNeutral ➝ Neutral$18.00 ➝ $21.00
5/21/2025
Warby Parker Inc. stock logo
WRBY
Warby Parker
Cowen
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy
5/21/2025
Warby Parker Inc. stock logo
WRBY
Warby Parker
Loop Capital
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy
5/21/2025
Warby Parker Inc. stock logo
WRBY
Warby Parker
Citigroup
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingNeutral ➝ Neutral$17.00 ➝ $22.00
5/21/2025
Warby Parker Inc. stock logo
WRBY
Warby Parker
Stifel Nicolaus
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetHold ➝ Hold$18.00 ➝ $21.00
5/21/2025
Warby Parker Inc. stock logo
WRBY
Warby Parker
TD Securities
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$20.00 ➝ $24.00
5/20/2025
LivaNova PLC stock logo
LIVN
LivaNova
Wolfe Research
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradePeer Perform ➝ Outperform$60.00
5/13/2025
LivaNova PLC stock logo
LIVN
LivaNova
Needham & Company LLC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$64.00 ➝ $64.00
(Data available from 6/7/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
LivaNova PLC stock logo
LIVN
LivaNova
$1.28B1.96$4.12 per share11.15$23.72 per share1.94
Envista Holdings Co. stock logo
NVST
Envista
$2.50B1.27$1.45 per share12.91$17.04 per share1.10
SI-BONE, Inc. stock logo
SIBN
SI-BONE
$176.60M4.56N/AN/A$4.18 per share4.52
Warby Parker Inc. stock logo
WRBY
Warby Parker
$795.09M2.84N/AN/A$3.08 per share7.02
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
LivaNova PLC stock logo
LIVN
LivaNova
$17.55M-$4.09109.4014.63N/A1.91%13.81%7.07%7/30/2025 (Estimated)
Envista Holdings Co. stock logo
NVST
Envista
-$1.12B-$6.53N/A15.511.27-44.56%3.86%2.21%8/6/2025 (Estimated)
SI-BONE, Inc. stock logo
SIBN
SI-BONE
-$43.34M-$0.64N/AN/AN/A-23.82%-22.51%-16.53%8/4/2025 (Estimated)
Warby Parker Inc. stock logo
WRBY
Warby Parker
-$63.20M-$0.12N/A216.07N/A-4.39%-8.26%-4.37%8/14/2025 (Estimated)

Latest SIBN, NVST, LIVN, and WRBY Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/5/2025Q1 2025
SI-BONE, Inc. stock logo
SIBN
SI-BONE
-$0.24-$0.15+$0.09-$0.15$45.13 million$47.29 million
5/1/2025Q1 2025
Envista Holdings Co. stock logo
NVST
Envista
$0.20$0.24+$0.04$0.10$608.17 million$616.90 million
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
LivaNova PLC stock logo
LIVN
LivaNova
N/AN/AN/AN/AN/A
Envista Holdings Co. stock logo
NVST
Envista
N/AN/AN/AN/AN/A
SI-BONE, Inc. stock logo
SIBN
SI-BONE
N/AN/AN/AN/AN/A
Warby Parker Inc. stock logo
WRBY
Warby Parker
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
LivaNova PLC stock logo
LIVN
LivaNova
0.46
3.37
2.87
Envista Holdings Co. stock logo
NVST
Envista
0.44
2.04
1.76
SI-BONE, Inc. stock logo
SIBN
SI-BONE
0.22
8.25
7.22
Warby Parker Inc. stock logo
WRBY
Warby Parker
N/A
2.47
2.06

Institutional Ownership

CompanyInstitutional Ownership
LivaNova PLC stock logo
LIVN
LivaNova
97.64%
Envista Holdings Co. stock logo
NVST
Envista
N/A
SI-BONE, Inc. stock logo
SIBN
SI-BONE
98.11%
Warby Parker Inc. stock logo
WRBY
Warby Parker
93.24%

Insider Ownership

CompanyInsider Ownership
LivaNova PLC stock logo
LIVN
LivaNova
0.29%
Envista Holdings Co. stock logo
NVST
Envista
1.30%
SI-BONE, Inc. stock logo
SIBN
SI-BONE
4.00%
Warby Parker Inc. stock logo
WRBY
Warby Parker
18.24%
CompanyEmployeesShares OutstandingFree FloatOptionable
LivaNova PLC stock logo
LIVN
LivaNova
2,90054.53 million54.15 millionOptionable
Envista Holdings Co. stock logo
NVST
Envista
12,700169.49 million169.95 millionOptionable
SI-BONE, Inc. stock logo
SIBN
SI-BONE
35042.62 million40.30 millionOptionable
Warby Parker Inc. stock logo
WRBY
Warby Parker
3,030104.50 million74.67 millionOptionable

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

LivaNova stock logo

LivaNova NASDAQ:LIVN

$45.95 +1.10 (+2.45%)
Closing price 06/6/2025 04:00 PM Eastern
Extended Trading
$45.88 -0.07 (-0.15%)
As of 06/6/2025 04:28 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

LivaNova PLC, a medical device company, designs, develops, manufactures, and sells therapeutic solutions worldwide. The company operates through Cardiopulmonary, Neuromodulation, and Advanced Circulatory Support segments. The Cardiopulmonary segment develops, produces, and sells cardiopulmonary products, including oxygenators, heart-lung machines, autotransfusion systems, perfusion tubing systems, cannulae, connect, and other related products. The Neuromodulation segment designs, develops, markets, and sells VNS Therapy System, an implantable pulse generator and connective lead that stimulates the vagus nerve; difficult-to-treat depression and drug-resistant epilepsy devices. The Advanced Circulatory Support segment develops, produces, and sells temporary life support products. It serves perfusionists, neurologists, neurosurgeons, and other physicians, as well as hospitals, other medical institutions, and healthcare providers. The company sells its products through direct sales representatives and independent distributors. LivaNova PLC was incorporated in 2015 and is headquartered in London, the United Kingdom.

Envista stock logo

Envista NYSE:NVST

$18.77 +0.09 (+0.48%)
Closing price 06/6/2025 03:59 PM Eastern
Extended Trading
$18.74 -0.03 (-0.16%)
As of 06/6/2025 04:52 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Envista Holdings Corporation, together with its subsidiaries, develops, manufactures, markets, and sells dental products in the United States, China, and internationally. The company operates in two segments, Specialty Products & Technologies, and Equipment & Consumables. The Specialty Products & Technologies segment offers dental implant systems, guided surgery systems, biomaterials, and prefabricated and custom-built prosthetics to oral surgeons, prosthodontists and periodontists, and general dentist; and brackets and wires, tubes and bands, archwires, clear aligners, digital orthodontic treatments, retainers, and other orthodontic laboratory products. This segment also provides software packages, which include DTX Studio Implant; DTX Studio Lab; and DTX Studio Clinic, a software package offered with its imaging products. It offers its products under the Nobel Biocare, Alpha-Bio Tec, Implant Direct, Nobel Procera, Ormco, Spark, Orascoptic, Damon, Insignia, AOA brands. The Equipment & Consumables segment provides dental equipment and supplies, including digital imaging systems, software, and other visualization/magnification systems; endodontic systems and related products; restorative materials, rotary burs, impression materials, bonding agents, and cements; and infection prevention products. This segment offers its products under the Dexis, DTX Studio, Kerr, Metrex, Total Care, Pentron, Optibond, Harmonize, Sonicfill, Sybron Endo, and CaviWipes to dental offices, clinics, and hospitals. Envista Holdings Corporation was incorporated in 2018 and is headquartered in Brea, California.

SI-BONE stock logo

SI-BONE NASDAQ:SIBN

$18.90 -0.16 (-0.84%)
Closing price 06/6/2025 04:00 PM Eastern
Extended Trading
$17.70 -1.20 (-6.32%)
As of 06/6/2025 07:56 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

SI-BONE, Inc., a medical device company, that operate to solve musculoskeletal disorders of the sacropelvic anatomy in the United States and internationally. It offers proprietary minimally invasive surgical implant system to address sacroiliac joint dysfunction and fusion, adult deformity and degeneration, and pelvic trauma; and implantable bone products. The company also provides iFuse-3D, a titanium implant that combines the triangular cross-section of the iFuse implant with the proprietary 3D-printed porous surface and fenestrated design; iFuse-TORQ, a set of 3D-printed threaded implants designed to treat pelvic trauma; and iFuse Bedrock Granite implant provides sacroiliac fusion and sacropelvic fixation as a foundational element for segmental spinal fusion. It markets its products primarily with a direct sales force, as well as through agents and resellers. SI-BONE, Inc. was incorporated in 2008 and is headquartered in Santa Clara, California.

Warby Parker stock logo

Warby Parker NYSE:WRBY

$21.61 +0.41 (+1.92%)
Closing price 06/6/2025 03:59 PM Eastern
Extended Trading
$21.62 +0.01 (+0.06%)
As of 06/6/2025 07:18 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Warby Parker Inc. provides eyewear products in the United States and Canada. The company offers eyeglasses, sunglasses, light-responsive lenses, blue-light-filtering lenses, non-prescription lenses, and contact lenses. It also provides accessories, such as cases, lenses kit with anti-fog spray, pouches, and anti-fog lens spray through its retail stores, website, and mobile apps. In addition, the company offers eye exams and vision tests. Warby Parker Inc. was incorporated in 2009 and is headquartered in New York, New York.